• Nenhum resultado encontrado

PDF EN Jornal Brasileiro de Pneumologia 5 22 english

N/A
N/A
Protected

Academic year: 2018

Share "PDF EN Jornal Brasileiro de Pneumologia 5 22 english"

Copied!
1
0
0

Texto

(1)

J Bras Pneumol. 2010;36(5):668

Any errors that occurred on my watch were committed in our quest for accuracy. However, I must emphasize that “the buck stops here”, and I therefore take full responsibility for all such errors.

Prof. Carvalho certainly has all of the qualities needed in order to ensure the continued advancement of the Journal. Although the priorities now are different than they were in 2005, the new challenges will be no less difficult to meet. The Brazilian community of pulmonologists has a duty to lend its full support to the new Editor-in-Chief. That support should primarily take the form of the submission of excellent scientific manuscripts, which will result in ever higher and more impressive impact factors!

I am extremely grateful to my fellow pulmonologists for having given me the opportunity to play a role in this mission.

All that remains now is the “happy ending” of my own projects and the beginning of an era of ongoing success for the Brazilian Journal of Pulmonology!

Prof. Dr. José Antônio Baddini Martinez Associate Professor in the Department of Clinical Medicine

University of São Paulo at Ribeirão Preto School of Medicine,

Ribeirão Preto, Brazil

References

1. Martinez JA. New times, old challenges. J Bras Pneumol. 2005,31(1):1-2.

Dear Readers:

The title above, a (translated) quotation from the Portuguese author Agustina Bessa-Luis, appropriately reflects the phase into which the Brazilian Journal of Pulmonology will enter after the XXXV Brazilian Pulmonology Conference, to be held in November in the city of Curitiba. At that event, after having spent six years at the helm of the Journal, I will be relinquishing the post of Editor-in-Chief to my successor, Prof. Carlos Roberto Ribeiro de Carvalho. According to the norms of the organization, I could remain in my position for another two years. However, the renewed demands of my academic career have led me to conclude that now is the time for me to hand over the reins.

Revisiting my first editorial as Editor-in-Chief, written in 2005,(1) I am extremely gratified

to note that the objectives I set forth at the beginning of my journey have been achieved in full. The most important achievements include the establishment of the Editor of the Brazilian Journal of Pulmonology as an autonomous member of the Brazilian Thoracic Association (BTA) Board of Directors; the full implementation of the functional regulations of the Journal; the indexing of the Journal for Medline, Scopus, and the ISI Web of Knowledge; and the attainment of an unprecedented level of international exposure for the Journal. In addition, in the year to come, the Journal of Citation Reports will issue the first impact factor for our Journal. Naturally, the satisfaction of having met these goals is shared by the other actors responsible for the success of the endeavor: the members of the last three BTA Boards, the BTA staff, the companies that provide services to the Journal, the peer reviewers, and, especially, the authors who have entrusted us with the precious products of their labors.

The End (of one thing is always the happy beginning of

something else)

The End: the end of one thing is always the happy beginning of something else

Referências

Documentos relacionados

The rate of resistance to antibiotics of Acinetobacter baumannii and Pseudomonas aeruginosa strains isolated from patients with MVAP was higher than those isolated from

This review focuses on a brief discussion about opportunistic infections still present in late diagnosed HIV-infected patients and describes new forms of HIV-related

xylosoxidans at our neonatal intensive care unit, beginning with the index case detected at November 2009 until cessation of the outbreak in April 2010, were evaluated

Our study lived up to our assumption to sug- gest that, the HCV core antigen based ELISA can be used for screening patients presenting with signs and symptoms of acute hepatitis, or

In the second phase of this study, pregnant women were prospectively followed to eval- uate postpartum effects of this infection as well as upon their neonates up to sixty (60)

Results: DNA sequencing revealed that 68.9% of multidrug-resistant strains have point muta- tions at codon 315 of the katG gene, 19.8% within the mabA-inhA promoter, and 98.0% at

Table 2 – Activity of selected antimicrobial agents when tested against 1825 Gram-positive pathogens from Latin America nations (2011)..

Results: Most patients were men (63%), with median age of 42 years, affected by chronic osteomyelitis (43%) or acute osteomyelitis associated to open fractures (32%), the majority